SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ANI Pharmaceuticals Reports Positive Phase 4 Trial Results at Ophthalmology Meeting

ANI Pharmaceuticals said SYNCHRONICITY trial results were presented as a late-breaking oral presentation at the American Academy of Ophthalmology 2026 Annual Meeting. The release says the trial reported six- and 24-month data.

ANIP